Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.044 USD | -2.22% | -3.61% | -34.71% |
Mar. 28 | Arcadia Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 28 | Transcript : Arcadia Biosciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.71% | 2.78M | |
+15.82% | 38.79B | |
-.--% | 10.98B | |
-4.50% | 7.52B | |
+4.77% | 6.81B | |
-3.63% | 6B | |
-11.01% | 5.59B | |
-3.85% | 5.66B | |
+33.14% | 5.26B | |
-13.34% | 4.56B |
- Stock Market
- Equities
- RKDA Stock
- News Arcadia Biosciences, Inc.
- HC Wainwright Adjusts Price Target on Arcadia Biosciences to $15 From $18, Keeps Buy Rating